Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012, Article ID 607276, 16 pages
http://dx.doi.org/10.1155/2012/607276
Review Article

Interplay between Human Cytomegalovirus and Intrinsic/Innate Host Responses: A Complex Bidirectional Relationship

1Section of Microbiology, Department of Hematology and Oncology “L. & A. Seragnoli”, University of Bologna, 40138 Bologna, Italy
2Department of Molecular Medicine, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Rome, Italy
3Department of Public Health and Microbiology, University of Turin, Turin, Italy

Received 21 December 2011; Accepted 22 March 2012

Academic Editor: Mohamed Lamkanfi

Copyright © 2012 Giada Rossini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. S. Mocarski, T. Shenk, and R. Pass, “Cytomegaloviruses,” in Fields Virology, D. Knipe and P. Howley, Eds., pp. 2701–2772, Lippincott Williams and Wilkins, Philadelphia, Pa, USA, 5th edition, 2007. View at Google Scholar
  2. F. Pereyra and R. H. Rubin, “Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients,” Current Opinion in Infectious Diseases, vol. 17, no. 4, pp. 357–361, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Sinzger, M. Digel, and G. Jahn, “Cytomegalovirus cell tropism,” Current Topics in Microbiology and Immunology, vol. 325, pp. 63–83, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. K. Isaacson, L. K. Juckem, and T. Compton, “Virus entry and innate immune activation,” Current Topics in Microbiology and Immunology, vol. 325, pp. 85–100, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. K. A. Simmen, J. Singh, B. G. M. Luukkonen et al., “Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 13, pp. 7140–7145, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. K. W. Boehme, J. Singh, S. T. Perry, and T. Compton, “Human cytomegalovirus elicits a coordinated cellular antiviral response via envelope glycoprotein B,” Journal of Virology, vol. 78, no. 3, pp. 1202–1211, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. P. D. Bieniasz, “Intrinsic immunity: a front-line defense against viral attack,” Nature Immunology, vol. 5, no. 11, pp. 1109–1115, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. S. R. Paludan, A. G. Bowie, K. A. Horan, and K. A. Fitzgerald, “Recognition of herpesviruses by the innate immune system,” Nature Reviews Immunology, vol. 11, no. 2, pp. 143–154, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. V. A. K. Rathinam and K. A. Fitzgerald, “Innate immune sensing of DNA viruses,” Virology, vol. 411, no. 2, pp. 153–162, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Sakuma, A. A. Mael, and Y. Ikeda, “Alpha interferon enhances TRIM5α-mediated antiviral activities in human and rhesus monkey cells,” Journal of Virology, vol. 81, no. 18, pp. 10201–10206, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Tanaka, H. Marusawa, H. Seno et al., “Anti-viral protein APOBEC3G is induced by interferon-α stimulation in human hepatocytes,” Biochemical and Biophysical Research Communications, vol. 341, no. 2, pp. 314–319, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Wang, S. M. Huong, M. L. Chiu, N. Raab-Traub, and E. S. Huang, “Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus,” Nature, vol. 424, no. 6947, pp. 456–461, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Chan, M. T. Nogalski, and A. D. Yurochko, “Activation of EGFR on monocytes is required for human cytomegalovirus entry and mediates cellular motility,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 52, pp. 22369–22374, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Soroceanu, A. Akhavan, and C. S. Cobbs, “Platelet-derived growth factor-α receptor activation is required for human cytomegalovirus infection,” Nature, vol. 455, no. 7211, pp. 391–395, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Wang, D. Y. Huang, S. M. Huong, and E. S. Huang, “Integrin αvβ3 is a coreceptor for human cytomegalovirus,” Nature Medicine, vol. 11, no. 5, pp. 515–521, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. M. T. Nogalski, G. Chan, E. V. Stevenson, S. Gray, and A. D. Yurochko, “Human cytomegalovirus-regulated paxillin in monocytes links cellular pathogenic motility to the process of viral entry,” Journal of Virology, vol. 85, no. 3, pp. 1360–1369, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Halary, A. Amara, H. Lortat-Jacob et al., “Human Cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection,” Immunity, vol. 17, no. 5, pp. 653–664, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Mezger, M. Steffens, C. Semmler et al., “Investigation of promoter variations in dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN) (CD209) and their relevance for human cytomegalovirus reactivation and disease after allogeneic stem-cell transplantation,” Clinical Microbiology and Infection, vol. 14, no. 3, pp. 228–234, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. O. Takeuchi and S. Akira, “Toll-like receptors; their physiological role and signal transduction system,” International Immunopharmacology, vol. 1, no. 4, pp. 625–635, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Compton, E. A. Kurt-Jones, K. W. Boehme et al., “Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2,” Journal of Virology, vol. 77, no. 8, pp. 4588–4596, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. L. K. Juckem, K. W. Boehme, A. L. Feire, and T. Compton, “Differential initiation of innate immune responses induced by human cytomegalovirus entry into fibroblast cells,” Journal of Immunology, vol. 180, no. 7, pp. 4965–4977, 2008. View at Google Scholar · View at Scopus
  22. K. W. Boehme, M. Guerrero, and T. Compton, “Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells,” Journal of Immunology, vol. 177, no. 10, pp. 7094–7102, 2006. View at Google Scholar · View at Scopus
  23. S. Kijpittayarit, A. J. Eid, R. A. Brown, C. V. Paya, and R. R. Razonable, “Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation,” Clinical Infectious Diseases, vol. 44, no. 10, pp. 1315–1320, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. R. A. Brown, J. H. Gralewski, and R. R. Razonable, “The R753Q polymorphism abrogates toll-like receptor 2 signaling in response to human cytomegalovirus,” Clinical Infectious Diseases, vol. 49, no. 9, pp. e96–e99, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Chan and L. J. Guilbert, “Ultraviolet-inactivated human cytomegalovirus induces placental syncytiotrophoblast apoptosis in a Toll-like receptor-2 and tumour necrosis factor-α dependent manner,” Journal of Pathology, vol. 210, no. 1, pp. 111–120, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. A. L. Blasius and B. Beutler, “Intracellular Toll-like Receptors,” Immunity, vol. 32, no. 3, pp. 305–315, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Krug, A. R. French, W. Barchet et al., “TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function,” Immunity, vol. 21, no. 1, pp. 107–119, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Tabeta, P. Georgel, E. Janssen et al., “Toll-like receptors 9 and 3 as essential complonents of innate immune defense against mouse cytomegalovirus infection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 10, pp. 3516–3521, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Delale, A. Paquin, C. Asselin-Paturel et al., “MyD88-dependent and -independent murine cytomegalovirus sensing for IFN-α release and initiation of immune responses in vivo,” Journal of Immunology, vol. 175, no. 10, pp. 6723–6732, 2005. View at Google Scholar · View at Scopus
  30. S. Varani, M. Cederarv, S. Feld et al., “Human cytomegalovirus differentially controls B cell and T cell responses through effects on plasmacytoid dendritic cells,” Journal of Immunology, vol. 179, no. 11, pp. 7767–7776, 2007. View at Google Scholar · View at Scopus
  31. A. C. Iversen, B. Steinkjer, N. Nilsen et al., “A proviral role for CpG in cytomegalovirus infection,” Journal of Immunology, vol. 182, no. 9, pp. 5672–5681, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Novak, C. F. Yu, C. Bussmann et al., “Putative association of a TLR9 promoter polymorphism with atopic eczema,” Allergy, vol. 62, no. 7, pp. 766–772, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Carvalho, C. Cunha, A. Carotti et al., “Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation,” Experimental Hematology, vol. 37, no. 9, pp. 1022–1029, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. S. C. Harwani, N. S. Lurain, M. R. Zariffard, and G. T. Spear, “Differential inhibition of human cytomegalovirus (HCMV) by toll-like receptor ligands mediated by interferon-beta in human foreskin fibroblasts and cervical tissue,” Virology Journal, vol. 4, p. 133, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Mezger, M. Bonin, T. Kessler, F. Gebhardt, H. Einsele, and J. Loeffler, “Toll-like receptor 3 has no critical role during early immune response of human monocyte-derived dendritic cells after infection with the human cytomegalovirus strain TB40E,” Viral Immunology, vol. 22, no. 6, pp. 343–351, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. S. E. Keating, M. Baran, and A. G. Bowie, “Cytosolic DNA sensors regulating type I interferon induction,” Trends in Immunology, vol. 32, no. 12, pp. 574–581, 2011. View at Publisher · View at Google Scholar
  37. V. R. DeFilippis, D. Alvarado, T. Sali, S. Rothenburg, and K. Früh, “Human cytomegalovirus induces the interferon response via the DNA sensor ZBP1,” Journal of Virology, vol. 84, no. 1, pp. 565–598, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. I. Scott, “Degradation of RIG-I following cytomegalovirus infection is independent of apoptosis,” Microbes and Infection, vol. 11, no. 12, pp. 973–979, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Ogawa, Y. Asai, M. Hashimoto, and H. Uchida, “Bacterial fimbriae activate human peripheral blood monocytes utilizing TLR2, CD14 and CD11a/CD18 as cellular receptors,” European Journal of Immunology, vol. 32, no. 9, pp. 2543–2550, 2002. View at Google Scholar
  40. A. L. Feire, H. Koss, and T. Compton, “Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 43, pp. 15470–15475, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. A. L. Feire, R. M. Roy, K. Manley, and T. Compton, “The glycoprotein B disintegrin-like domain binds beta 1 integrin to mediate cytomegalovirus entry,” Journal of Virology, vol. 84, no. 19, pp. 10026–10037, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Compton, “Receptors and immune sensors: the complex entry path of human cytomegalovirus,” Trends in Cell Biology, vol. 14, no. 1, pp. 5–8, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. D. A. Abate, S. Watanabe, and E. S. Mocarski, “Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response,” Journal of Virology, vol. 78, no. 20, pp. 10995–11006, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. E. P. Browne and T. Shenk, “Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 20, pp. 11439–11444, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Y. Liu, D. J. Sanchez, and G. Cheng, “New developments in the induction and antiviral effectors of type I interferon,” Current Opinion in Immunology, vol. 23, no. 1, pp. 57–64, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. R. N. Douville and J. Hiscott, “The interface between the innate interferon response and expression of host retroviral restriction factors.,” Cytokine, vol. 52, no. 1-2, pp. 108–115, 2010. View at Google Scholar · View at Scopus
  47. E. L. Reineke and H. Y. Kao, “Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies,” International Journal of Biological Sciences, vol. 5, no. 4, pp. 366–376, 2009. View at Google Scholar · View at Scopus
  48. S. R. Cantrell and W. A. Bresnahan, “Human cytomegalovirus (HCMV) UL82 gene product (pp71) relieves hDaxx-mediated repression of HCMV replication,” Journal of Virology, vol. 80, no. 12, pp. 6188–6191, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. N. Tavalai and T. Stamminger, “New insights into the role of the subnuclear structure ND10 for viral infection,” Biochimica et Biophysica Acta, vol. 1783, no. 11, pp. 2207–2221, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. K. A. Fitzgerald, “The interferon inducible gene: viperin,” Journal of Interferon and Cytokine Research, vol. 31, no. 1, pp. 131–135, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. N. Tavalai and T. Stamminger, “Intrinsic cellular defense mechanisms targeting human cytomegalovirus,” Virus Research, vol. 157, no. 2, pp. 128–133, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. K. C. Chin and P. Cresswell, “Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 26, pp. 15125–15130, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Gariglio, M. Mondini, M. De Andrea, and S. Landolfo, “The multifaceted interferon-inducible p200 family proteins: from cell biology to human pathology,” Journal of Interferon and Cytokine Research, vol. 31, no. 1, pp. 159–172, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. N. Kerur, M. V. Veettil, N. Sharma-Walia et al., “IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection,” Cell Host and Microbe, vol. 9, no. 5, pp. 363–375, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. L. Unterholzner, S. E. Keating, M. Baran et al., “IFI16 is an innate immune sensor for intracellular DNA,” Nature Immunology, vol. 11, no. 11, pp. 997–1004, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. G. R. Gariano, V. Dell'Oste, M. Bronzini et al., “The intracellular DNA sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication,” PLoS Pathogens, vol. 8, Article ID e1002498, 2012. View at Google Scholar
  57. J. Y. Seo, R. Yaneva, E. R. Hinson, and P. Cresswell, “Human cytomegalovirus directly induces the antiviral protein viperin to enhance infectivity,” Science, vol. 332, no. 6033, pp. 1093–1097, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. E. Ø. Kvale, J. Dalgaard, F. Lund-Johansen et al., “CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection,” Blood, vol. 107, no. 5, pp. 2022–2029, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. A. D. Yurochko, “Human cytomegalovirus modulation of signal transduction,” Current Topics in Microbiology and Immunology, vol. 325, pp. 205–220, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Sinclair and P. Sissons, “Latent and persistent infections of monocytes and macrophages,” Intervirology, vol. 39, no. 5-6, pp. 293–301, 1996. View at Google Scholar · View at Scopus
  61. J. Taylor-Wiedeman, J. G. P. Sissons, L. K. Borysiewicz, and J. H. Sinclair, “Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells,” Journal of General Virology, vol. 72, no. 9, pp. 2059–2064, 1991. View at Google Scholar · View at Scopus
  62. C. Sinzger, K. Eberhardt, Y. Cavignac et al., “Macrophage cultures are susceptible to lytic productive infection by endothelial-cell-propagated human cytomegalovirus strains and present viral IE1 protein to CD4+ T cells despite late downregulation of MHC class II molecules,” Journal of General Virology, vol. 87, no. 7, pp. 1853–1862, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Riegler, H. Hebart, H. Einsele, P. Brossart, G. Jahn, and C. Sinzger, “Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus,” Journal of General Virology, vol. 81, no. 2, pp. 393–399, 2000. View at Google Scholar · View at Scopus
  64. G. P. A. Rice, R. D. Schrier, and M. B. A. Oldstone, “Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products,” Proceedings of the National Academy of Sciences of the United States of America, vol. 81, no. 19 I, pp. 6134–6138, 1984. View at Google Scholar · View at Scopus
  65. G. Frascaroli, S. Varani, B. Moepps, C. Sinzger, M. P. Landini, and T. Mertens, “Human cytomegalovirus subverts the functions of monocytes, impairing chemokine-mediated migration and leukocyte recruitment,” Journal of Virology, vol. 80, no. 15, pp. 7578–7589, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. C. E. Ibanez, R. Schrier, P. Ghazal, C. Wiley, and J. A. Nelson, “Human cytomegalovirus productively infects primary differentiated macrophages,” Journal of Virology, vol. 65, no. 12, pp. 6581–6588, 1991. View at Google Scholar · View at Scopus
  67. G. Gerna, E. Percivalle, D. Lilleri et al., “Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells,” Journal of General Virology, vol. 86, no. 2, pp. 275–284, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. D. Hargett and T. E. Shenk, “Experimental human cytomegalovirus latency in CD14+ monocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 46, pp. 20039–20044, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. M. B. Reeves, P. A. MacAry, P. J. Lehner, J. G. P. Sissons, and J. H. Sinclair, “Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 11, pp. 4140–4145, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. J. Sinclair, “Chromatin structure regulates human cytomegalovirus gene expression during latency, reactivation and lytic infection,” Biochimica et Biophysica Acta, vol. 1799, no. 3-4, pp. 286–295, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. M. B. Reeves and T. Compton, “Inhibition of inflammatory Interleukin-6 activity via ERK-MAPK signaling antagonizes human cytomegalovirus reactivation from dendritic cells from latency,” Journal of Virology, vol. 85, no. 23, pp. 12750–12758, 2011. View at Publisher · View at Google Scholar
  72. M. S. Smith, G. L. Bentz, J. S. Alexander, and A. D. Yurochko, “Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence,” Journal of Virology, vol. 78, no. 9, pp. 4444–4453, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. G. Chan, E. R. Bivins-Smith, M. S. Smith, P. M. Smith, and A. D. Yurochko, “Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage,” Journal of Immunology, vol. 181, no. 1, pp. 698–711, 2008. View at Google Scholar · View at Scopus
  74. S. Varani, G. Frascaroli, M. Homman-Loudiyi, S. Feld, M. P. Landini, and C. Söderberg-Nauclér, “Human cytomegalovirus inhibits the migration of immature dendritic cells by down-regulating cell-surface CCR1 and CCR5,” Journal of Leukocyte Biology, vol. 77, no. 2, pp. 219–228, 2005. View at Publisher · View at Google Scholar · View at Scopus
  75. K. Beck, U. Meyer-König, M. Weidmann, C. Nern, and F. T. Hufert, “Human cytomegalovirus impairs dendritic cell function: a novel mechanism of human cytomegalovirus immune escape,” European Journal of Immunology, vol. 33, no. 6, pp. 1528–1538, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. G. Frascaroli, S. Varani, N. Blankenhorn et al., “Human cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of the cytoskeleton, and release of macrophage migration inhibitory factor,” Journal of Immunology, vol. 182, no. 1, pp. 477–488, 2009. View at Google Scholar · View at Scopus
  77. M. J. Raftery, E. Möncke-Buchner, H. Matsumura et al., “Unravelling the interaction of human cytomegalovirus with dendritic cells by using SuperSAGE,” Journal of General Virology, vol. 90, no. 9, pp. 2221–2233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. S. Gredmark and C. Söderberg-Nauclér, “Human cytomegalovirus inhibits differentiation of monocytes into dendritic cells with the consequence of depressed immunological functions,” Journal of Virology, vol. 77, no. 20, pp. 10943–10956, 2003. View at Publisher · View at Google Scholar · View at Scopus
  79. S. Gredmark, T. Tilburgs, and C. Söderberg-Nauclé, “Human cytomegalovirus inhibits cytokine-induced macrophage differentiation,” Journal of Virology, vol. 78, no. 19, pp. 10378–10389, 2004. View at Publisher · View at Google Scholar · View at Scopus
  80. V. Gafa, O. Manches, A. Pastor et al., “Human cytomegalovirus downregulates complement receptors (CR3, CR4) and decreases phagocytosis by macrophages,” Journal of Medical Virology, vol. 76, no. 3, pp. 361–366, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. U. Grigoleit, S. Riegler, H. Einsele et al., “Human cytomegalovirus induces a direct inhibitory effect on antigen presentation by monocyte-derived immature dendritic cells,” British Journal of Haematology, vol. 119, no. 1, pp. 189–198, 2002. View at Publisher · View at Google Scholar · View at Scopus
  82. M. Moutaftsi, A. M. Mehl, L. K. Borysiewicz, and Z. Tabi, “Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells,” Blood, vol. 99, no. 8, pp. 2913–2921, 2002. View at Publisher · View at Google Scholar · View at Scopus
  83. M. Moutaftsi, P. Brennan, S. A. Spector, and Z. Tabi, “Impaired lymphoid chemokine-mediated migration due to a block on the chemokine receptor switch in human cytomegalovirus-infected dendritic cells,” Journal of Virology, vol. 78, no. 6, pp. 3046–3054, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. L. Hertel, V. G. Lacaille, H. Strobl, E. D. Mellins, and E. S. Mocarski, “Susceptibility of immature and mature langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus,” Journal of Virology, vol. 77, no. 13, pp. 7563–7574, 2003. View at Publisher · View at Google Scholar · View at Scopus
  85. A. W. Lee, L. Hertel, R. K. Louie et al., “Human cytomegalovirus alters localization of MHC class II and dendrite morphology in mature Langerhans cells,” Journal of Immunology, vol. 177, no. 6, pp. 3960–3971, 2006. View at Google Scholar · View at Scopus
  86. B. Senechal, A. M. Boruchov, J. L. Reagan, D. N. J. Hart, and J. W. Young, “Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83,” Blood, vol. 103, no. 11, pp. 4207–4215, 2004. View at Publisher · View at Google Scholar · View at Scopus
  87. M. J. Raftery, M. Schwab, S. M. Eibert, Y. Samstag, H. Walczak, and G. Schönrich, “Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy,” Immunity, vol. 15, no. 6, pp. 997–1009, 2001. View at Publisher · View at Google Scholar · View at Scopus
  88. C. S. Wagner, L. Walther-Jallow, E. Buentke, H. G. Ljunggren, A. Achour, and B. J. Chambers, “Human cytomegalovirus-derived protein UL18 alters the phenotype and function of monocyte-derived dendritic cells,” Journal of Leukocyte Biology, vol. 83, no. 1, pp. 56–63, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. M. J. Raftery, D. Wieland, S. Gronewald, A. A. Kraus, T. Giese, and G. Schönrich, “Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10,” Journal of Immunology, vol. 173, no. 5, pp. 3383–3391, 2004. View at Google Scholar · View at Scopus
  90. M. J. Raftery, M. Hitzler, F. Winau et al., “Inhibition of CD1 antigen presentation by human cytomegalovirus,” Journal of Virology, vol. 82, no. 9, pp. 4308–4319, 2008. View at Publisher · View at Google Scholar · View at Scopus
  91. J. V. Spencer, K. M. Lockridge, P. A. Barry et al., “Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10,” Journal of Virology, vol. 76, no. 3, pp. 1285–1292, 2002. View at Google Scholar · View at Scopus
  92. J. V. Spencer, “The cytomegalovirus homolog of interleukin-10 requires phosphatidylinositol 3-kinase activity for inhibition of cytokine synthesis in monocytes,” Journal of Virology, vol. 81, no. 4, pp. 2083–2086, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. W. L. W. Chang, P. A. Barry, R. Szubin, D. Wang, and N. Baumgarth, “Human cytomegalovirus suppresses type I interferon secretion by plasmacytoid dendritic cells through its interleukin 10 homolog,” Virology, vol. 390, no. 2, pp. 330–337, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. A. W. Sylwester, B. L. Mitchell, J. B. Edgar et al., “Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects,” Journal of Experimental Medicine, vol. 202, no. 5, pp. 673–685, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. L. E. Gamadia, E. B. M. Remmerswaal, J. F. Weel, F. Bemelman, R. A. W. Van Lier, and I. J. M. Ten Berge, “Primary immune responses to human CMV: a critical role for IFN-γ-producing CD4+ T cells in protection against CMV disease,” Blood, vol. 101, no. 7, pp. 2686–2692, 2003. View at Publisher · View at Google Scholar · View at Scopus
  96. M. Mandron, H. Martin, B. Bonjean, J. Lulé, E. Tartour, and C. Davrinche, “Dendritic cell-induced apoptosis of human cytomegalovirus-infected fibroblasts promotes cross-presentation of pp65 to CD8+ T cells,” Journal of General Virology, vol. 89, no. 1, pp. 78–86, 2008. View at Publisher · View at Google Scholar · View at Scopus
  97. C. A. Biron, K. S. Byron, and J. L. Sullivan, “Severe herpesvirus infections in an adolescent without natural killer cells,” New England Journal of Medicine, vol. 320, no. 26, pp. 1731–1735, 1989. View at Google Scholar · View at Scopus
  98. R. Gazit, B. Z. Garty, Y. Monselise et al., “Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome,” Blood, vol. 103, no. 5, pp. 1965–1966, 2004. View at Publisher · View at Google Scholar · View at Scopus
  99. C. A. Biron, K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather, “Natural killer cells in antiviral defense: function and regulation by innate cytokines,” Annual Review of Immunology, vol. 17, pp. 189–220, 1999. View at Publisher · View at Google Scholar · View at Scopus
  100. L. Moretta, G. Ferlazzo, C. Bottino et al., “Effector and regulatory events during natural killer-dendritic cell interactions,” Immunological Reviews, vol. 214, no. 1, pp. 219–228, 2006. View at Publisher · View at Google Scholar · View at Scopus
  101. L. L. Lanier, “Natural killer cells: roundup,” Immunological Reviews, vol. 214, no. 1, pp. 5–8, 2006. View at Publisher · View at Google Scholar · View at Scopus
  102. L. L. Lanier, “Up on the tightrope: natural killer cell activation and inhibition,” Nature Immunology, vol. 9, no. 5, pp. 495–502, 2008. View at Publisher · View at Google Scholar · View at Scopus
  103. B. N. Lilley and H. L. Ploegh, “Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond,” Immunological Reviews, vol. 207, pp. 126–144, 2005. View at Publisher · View at Google Scholar · View at Scopus
  104. K. Karre, H. G. Ljunggren, G. Piontek, and R. Kiessling, “Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy,” Nature, vol. 319, no. 6055, pp. 675–678, 1986. View at Google Scholar · View at Scopus
  105. C. Cerboni, M. Mousavi-Jazi, A. Linde et al., “Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts,” Journal of Immunology, vol. 164, no. 9, pp. 4775–4782, 2000. View at Google Scholar · View at Scopus
  106. J. M. Fletcher, H. G. Prentice, and J. E. Grundy, “Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function- associated antigen-3 (LFA-3) expression and not with the CMV-induced down- regulation of cell surface class I HLA,” Journal of Immunology, vol. 161, no. 5, pp. 2365–2374, 1998. View at Google Scholar · View at Scopus
  107. K. Kärre, “Clever, cleverer, cleverest,” Nature Immunology, vol. 3, no. 6, pp. 505–506, 2002. View at Publisher · View at Google Scholar · View at Scopus
  108. G. W. G. Wilkinson, P. Tomasec, R. J. Stanton et al., “Modulation of natural killer cells by human cytomegalovirus,” Journal of Clinical Virology, vol. 41, no. 3, pp. 206–212, 2008. View at Publisher · View at Google Scholar · View at Scopus
  109. S. Beck and B. G. Barrell, “Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens,” Nature, vol. 331, no. 6153, pp. 269–272, 1988. View at Google Scholar · View at Scopus
  110. H. Browne, G. Smith, S. Beck, and T. Minson, “A complex between the MHC class I homologue encoded by human cytomegalovirus and β2 microglobulin,” Nature, vol. 347, no. 6295, pp. 770–772, 1990. View at Publisher · View at Google Scholar · View at Scopus
  111. M. L. Fahnestock, J. L. Johnson, R. M. Renny Feldman, J. M. Neveu, W. S. Lane, and P. J. Bjorkman, “The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides,” Immunity, vol. 3, no. 5, pp. 583–590, 1995. View at Google Scholar · View at Scopus
  112. T. L. Chapman, A. P. Heikema, and P. J. Bjorkman, “The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18,” Immunity, vol. 11, no. 5, pp. 603–613, 1999. View at Google Scholar · View at Scopus
  113. D. Cosman, N. Fanger, L. Borges et al., “A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules,” Immunity, vol. 7, no. 2, pp. 273–282, 1997. View at Publisher · View at Google Scholar · View at Scopus
  114. B. E. Willcox, L. M. Thomas, and P. J. Bjorkman, “Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor,” Nature Immunology, vol. 4, no. 9, pp. 913–919, 2003. View at Publisher · View at Google Scholar · View at Scopus
  115. M. Colonna, F. Navarro, T. Bellón et al., “A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells,” Journal of Experimental Medicine, vol. 186, no. 11, pp. 1809–1818, 1997. View at Publisher · View at Google Scholar · View at Scopus
  116. C. S. Wagner, H. G. Ljunggren, and A. Achour, “Immune modulation by the human cytomegalovirus-encoded molecule UL18, a mystery yet to be solved,” Journal of Immunology, vol. 180, no. 1, pp. 19–24, 2008. View at Google Scholar · View at Scopus
  117. C. Cerboni, A. Achour, A. Warnmark et al., “Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR-1/ILT2/CD85j,” European Journal of Immunology, vol. 36, no. 3, pp. 732–741, 2006. View at Google Scholar
  118. M. Vales-Gomez, M. Shiroishi, K. Maenaka, and H. T. Reyburn, “Genetic variability of the major histocompatibility complex class I homologue encoded by human cytomegalovirus leads to differential binding to the inhibitory receptor ILT2,” Journal of Virology, vol. 79, no. 4, pp. 2251–2260, 2005. View at Publisher · View at Google Scholar · View at Scopus
  119. K. Ahn, A. Gruhler, B. Galocha et al., “The ER-luminal domain of the HCMV glypcoprotein US6 inhibits peptide translocation by TAP,” Immunity, vol. 6, no. 5, pp. 613–621, 1997. View at Publisher · View at Google Scholar · View at Scopus
  120. H. Hengel, J. O. Koopmann, T. Flohr et al., “A viral ER-resident glycoprotein inactivates the MHC-endoced peptide transporter,” Immunity, vol. 6, no. 5, pp. 623–632, 1997. View at Publisher · View at Google Scholar · View at Scopus
  121. P. J. Lehner, J. T. Karttunen, G. W. G. Wilkinson, and P. Cresswell, “The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 13, pp. 6904–6909, 1997. View at Publisher · View at Google Scholar · View at Scopus
  122. P. Tomasec, V. M. Braud, C. Rickards et al., “Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40,” Science, vol. 287, no. 5455, pp. 1031–1033, 2000. View at Publisher · View at Google Scholar
  123. M. Ulbrecht, S. Martinozzi, M. Grzeschik et al., “Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis,” Journal of Immunology, vol. 164, no. 10, pp. 5019–5022, 2000. View at Google Scholar · View at Scopus
  124. C. Cerboni, M. Mousavi-Jazi, H. Wakiguchi, E. Carbone, K. Karre, and K. Soderstrom, “Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity,” European Journal of Immunology, vol. 31, no. 10, pp. 2926–2935, 2001. View at Google Scholar
  125. E. C. Y. Wang, B. McSharry, C. Retiere et al., “UL40-mediated NK evasion during productive infection with human cytomegalovirus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 11, pp. 7570–7575, 2002. View at Publisher · View at Google Scholar · View at Scopus
  126. R. A. Eagle and J. Trowsdale, “Promiscuity and the single receptor: NKG2D,” Nature Reviews Immunology, vol. 7, no. 9, pp. 737–744, 2007. View at Publisher · View at Google Scholar · View at Scopus
  127. S. A. Welte, C. Sinzger, S. Z. Lutz et al., “Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein,” European Journal of Immunology, vol. 33, no. 1, pp. 194–203, 2003. View at Publisher · View at Google Scholar · View at Scopus
  128. C. Dunn, N. J. Chalupny, C. L. Sutherland et al., “Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity,” Journal of Experimental Medicine, vol. 197, no. 11, pp. 1427–1439, 2003. View at Publisher · View at Google Scholar · View at Scopus
  129. A. Rölle, M. Mousavi-Jazi, M. Eriksson et al., “Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein,” Journal of Immunology, vol. 171, no. 2, pp. 902–908, 2003. View at Google Scholar · View at Scopus
  130. O. Ashiru, N. J. Bennett, L. H. Boyle, M. Thomas, J. Trowsdale, and M. R. Wills, “NKG2D ligand MICA is retained in the cis-Golgi apparatus by human cytomegalovirus protein UL142,” Journal of Virology, vol. 83, no. 23, pp. 12345–12354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  131. N. J. Bennett, O. Ashiru, F. J. E. Morgan et al., “Intracellular sequestration of the NKG2D ligand ULBP3 by human cytomegalovirus,” Journal of Immunology, vol. 185, no. 2, pp. 1093–1102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  132. N. J. Chalupny, A. Rein-Weston, S. Dosch, and D. Cosman, “Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142,” Biochemical and Biophysical Research Communications, vol. 346, no. 1, pp. 175–181, 2006. View at Google Scholar
  133. N. Stern-Ginossar, N. Elefant, A. Zimmermann et al., “Host immune system gene targeting by a viral miRNA,” Science, vol. 317, no. 5836, pp. 376–381, 2007. View at Publisher · View at Google Scholar · View at Scopus
  134. P. Tomasec, E. C. Wang, A. J. Davison et al., “Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141,” Nature Immunology, vol. 6, no. 2, pp. 181–188, 2005. View at Publisher · View at Google Scholar
  135. V. Prod'homme, D. M. Sugrue, R. J. Stanton et al., “Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112,” Journal of General Virology, vol. 91, no. 8, pp. 2034–2039, 2010. View at Publisher · View at Google Scholar · View at Scopus
  136. C. Bottino, R. Castriconi, D. Pende et al., “Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule,” Journal of Experimental Medicine, vol. 198, no. 4, pp. 557–567, 2003. View at Publisher · View at Google Scholar · View at Scopus
  137. T. A. N. Cha, E. Tom, G. W. Kemble, G. M. Duke, E. S. Mocarski, and R. R. Spaete, “Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains,” Journal of Virology, vol. 70, no. 1, pp. 78–83, 1996. View at Google Scholar · View at Scopus
  138. T. I. Arnon, H. Achdout, O. Levi et al., “Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus,” Nature Immunology, vol. 6, no. 5, pp. 515–523, 2005. View at Publisher · View at Google Scholar · View at Scopus
  139. Y. Zou, W. Bresnahan, R. T. Taylor, and P. Stastny, “Effect of human cytomegalovirus on expression of MHC class I-related chains A,” Journal of Immunology, vol. 174, no. 5, pp. 3098–3104, 2005. View at Google Scholar · View at Scopus
  140. Y. Zhang, M. Han, R. Vorhaben, C. Giang, B. Lavingia, and P. Stastny, “Study of MICA alleles in 201 African Americans by multiplexed single nucleotide extension (MSNE) typing,” Human Immunology, vol. 64, no. 1, pp. 130–136, 2003. View at Publisher · View at Google Scholar · View at Scopus
  141. Y. Zhang, A. M. Lazaro, B. Lavingia, and P. Stastny, “Typing for all known MICA alleles by group-specific PRC and SSOP,” Human Immunology, vol. 62, no. 6, pp. 620–631, 2001. View at Publisher · View at Google Scholar · View at Scopus
  142. G. M. Venkataraman, D. Suciu, V. Groh, J. M. Boss, and T. Spies, “Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D,” Journal of Immunology, vol. 178, no. 2, pp. 961–969, 2007. View at Google Scholar · View at Scopus
  143. Y. Yu, M. Hagihara, K. Ando et al., “Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells,” Journal of Immunology, vol. 166, no. 3, pp. 1590–1600, 2001. View at Google Scholar · View at Scopus
  144. M. D. Chiesa, M. Vitale, S. Carlomagno, G. Ferlazzo, L. Moretta, and A. Moretta, “The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors,” European Journal of Immunology, vol. 33, no. 6, pp. 1657–1666, 2003. View at Publisher · View at Google Scholar · View at Scopus
  145. G. Ferlazzo, M. L. Tsang, L. Moretta, G. Melioli, R. M. Steinman, and C. Münz, “Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells,” Journal of Experimental Medicine, vol. 195, no. 3, pp. 343–351, 2002. View at Publisher · View at Google Scholar · View at Scopus
  146. N. C. Fernandez, A. Lozier, C. Flament et al., “Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo,” Nature Medicine, vol. 5, no. 4, pp. 405–411, 1999. View at Publisher · View at Google Scholar · View at Scopus
  147. F. Gerosa, B. Baldani-Guerra, C. Nisii, V. Marchesini, G. Carra, and G. Trinchieri, “Reciprocal activating interaction between natural killer cells and dendritic cells,” Journal of Experimental Medicine, vol. 195, no. 3, pp. 327–333, 2002. View at Publisher · View at Google Scholar · View at Scopus
  148. D. Pende, R. Castriconi, P. Romagnani et al., “Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction,” Blood, vol. 107, no. 5, pp. 2030–2036, 2006. View at Publisher · View at Google Scholar · View at Scopus
  149. M. Vitale, M. D. Chiesa, S. Carlomagno et al., “NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor,” Blood, vol. 106, no. 2, pp. 566–571, 2005. View at Google Scholar
  150. G. Magri, A. Muntasell, N. Romo et al., “NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies,” Blood, vol. 117, no. 3, pp. 848–856, 2011. View at Publisher · View at Google Scholar · View at Scopus
  151. N. Romo, G. Magri, A. Muntasell et al., “Natural killer cell-mediated response to human cytomegalovirus-infected macrophages is modulated by their functional polarization,” Journal of Leukocyte Biology, vol. 90, no. 4, pp. 717–726, 2011. View at Google Scholar
  152. D. Michel and T. Mertens, “Antiviral intervention, resistance and perspectives,” in Cytomegaloviruses Molecular Biology and Immunology, M. J. Reddehase, Ed., pp. 573–590, Caister Academic Press, Norfolk, UK, 2006. View at Google Scholar
  153. M. Scholz, H. W. Doerr, and J. Cinatl, “Inhibition of cytomegalovirus immediate early gene expression: a therapeutic option?” Antiviral Research, vol. 49, no. 3, pp. 129–145, 2001. View at Publisher · View at Google Scholar · View at Scopus
  154. B. Mercorelli, D. Lembo, G. Palù, and A. Loregian, “Early inhibitors of human cytomegalovirus: state-of-art and therapeutic perspectives,” Pharmacology and Therapeutics, vol. 131, no. 3, pp. 309–329, 2011. View at Publisher · View at Google Scholar · View at Scopus
  155. T. Ghosh, K. Chattopadhyay, M. Marschall, P. Karmakar, P. Mandal, and B. Ray, “Focus on antivirally active sulfated polysaccharides: from structure-activity analysis to clinical evaluation,” Glycobiology, vol. 19, no. 1, pp. 2–15, 2009. View at Publisher · View at Google Scholar · View at Scopus
  156. J. H. Andersen, S. A. Osbakk, L. H. Vorland, T. Traavik, and T. J. Gutteberg, “Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts,” Antiviral Research, vol. 51, no. 2, pp. 141–149, 2001. View at Publisher · View at Google Scholar · View at Scopus
  157. A. R. Borges and C. L. Schengrund, “Dendrimers and antivirals: a review,” Current Drug Targets, vol. 5, no. 3, pp. 247–254, 2005. View at Publisher · View at Google Scholar · View at Scopus
  158. A. Luganini, A. Giuliani, G. Pirri, L. Pizzuto, S. Landolfo, and G. Gribaudo, “Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate,” Antiviral Research, vol. 85, no. 3, pp. 532–540, 2010. View at Publisher · View at Google Scholar · View at Scopus
  159. A. Luganini, S. F. Nicoletto, L. Pizzuto et al., “Inhibition of herpes simplex virus type 1 and type 2 infections by peptide-derivatized dendrimers,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 7, pp. 3231–3239, 2011. View at Google Scholar
  160. W. Britt, “Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease,” Current Topics in Microbiology and Immunology, vol. 325, pp. 417–470, 2008. View at Publisher · View at Google Scholar
  161. G. Hahn, M. G. Revello, M. Patrone et al., “Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes,” Journal of Virology, vol. 78, no. 18, pp. 10023–10033, 2004. View at Publisher · View at Google Scholar · View at Scopus
  162. B. J. Ryckman, B. L. Rainish, M. C. Chase et al., “Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells,” Journal of Virology, vol. 82, no. 1, pp. 60–70, 2008. View at Publisher · View at Google Scholar · View at Scopus
  163. S. Straschewski, M. Patrone, P. Walther, A. Gallina, T. Mertens, and G. Frascaroli, “Protein pUL128 of human cytomegalovirus is necessary for monocyte infection and blocking of migration,” Journal of Virology, vol. 85, no. 10, pp. 5150–5158, 2011. View at Publisher · View at Google Scholar · View at Scopus
  164. M. K. Isaacson and T. Compton, “Human cytomegalovirus glycoprotein B is required for virus entry and cell-to-cell spread but not for virion attachment, assembly, or egress,” Journal of Virology, vol. 83, no. 8, pp. 3891–3903, 2009. View at Publisher · View at Google Scholar · View at Scopus
  165. T. R. Jones, S. W. Lee, S. V. Johann et al., “Specific inhibition of human cytomegalovirus glycoprotein B-mediated fusion by a novel thiourea small molecule,” Journal of Virology, vol. 78, no. 3, pp. 1289–1300, 2004. View at Publisher · View at Google Scholar · View at Scopus
  166. M. Lopper and T. Compton, “Coiled-coil domains in glycoproteins B and H are involved in human cytomegalovirus membrane fusion,” Journal of Virology, vol. 78, no. 15, pp. 8333–8341, 2004. View at Publisher · View at Google Scholar · View at Scopus
  167. E. P. English, R. S. Chumanov, S. H. Gellman, and T. Compton, “Rational development of β-peptide inhibitors of human cytomegalovirus entry,” Journal of Biological Chemistry, vol. 281, no. 5, pp. 2661–2667, 2006. View at Publisher · View at Google Scholar · View at Scopus
  168. A. M. Krieg, “Therapeutic potential of toll-like receptor 9 activation,” Nature Reviews Drug Discovery, vol. 5, no. 6, pp. 471–484, 2006. View at Publisher · View at Google Scholar · View at Scopus
  169. D. M. Klinman, “Immunotherapeutic uses of CpG oligodeoxynucleotides,” Nature Reviews Immunology, vol. 4, no. 4, pp. 249–258, 2004. View at Google Scholar · View at Scopus
  170. A. Luganini, P. Caposio, S. Landolfo, and G. Gribaudo, “Phosphorothioate-modified oligodeoxynucleotides inhibit human cytomegalovirus replication by blocking virus entry,” Antimicrobial Agents and Chemotherapy, vol. 52, no. 3, pp. 1111–1120, 2008. View at Publisher · View at Google Scholar
  171. A. Lux, S. Aschermann, M. Biburger, and F. Nimmerjahn, “The pro and anti-inflammatory activities of immunoglobulin G,” Annals of the Rheumatic Diseases, vol. 69, supplement 1, pp. i92–i96, 2010. View at Google Scholar
  172. N. Bonaros, B. Mayer, T. Schachner, G. Laufer, and A. Kocher, “CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis,” Clinical Transplantation, vol. 22, no. 1, pp. 89–97, 2008. View at Publisher · View at Google Scholar · View at Scopus
  173. P. Raanani, A. Gafter-Gvili, M. Paul, I. Ben-Bassat, L. Leibovici, and O. Shpilberg, “Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation.,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD006501, 2008. View at Google Scholar · View at Scopus
  174. S. P. Adler and G. Nigro, “Findings and conclusions from CMV hyperimmune globulin treatment trials,” Journal of Clinical Virology, vol. 46, supplement 4, pp. S54–S57, 2009. View at Google Scholar
  175. A. Funaro, G. Gribaudo, A. Luganini et al., “Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells,” BMC Biotechnology, vol. 8, p. 85, 2008. View at Publisher · View at Google Scholar · View at Scopus
  176. A. Macagno, N. L. Bernasconi, F. Vanzetta et al., “Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex,” Journal of Virology, vol. 84, no. 2, pp. 1005–1013, 2010. View at Publisher · View at Google Scholar · View at Scopus